MedTrace Logo

Cluster RCT - Evaluating Effectiveness of a Guide and Tools for Influenza Immunization Campaign Planners

NCT01207518 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2011-07-28

No results posted yet for this study

Summary

During the 2010-2011 and the 2011-2012 seasonal influenza immunization campaigns, we will recruit a minimum of 46 healthcare organizations to either conduct their campaigns as usual or to use the "Successful Influenza Immunization Campaigns for Healthcare Personnel: A Guide for Campaign Planners and a web-based grab-and-go Tool Kit. At the end of the campaign season we will evaluate the impact of the Guide and web-based tools and assess whether there were changes in immunization rates within each organization and/or if there were significant changes in the management of the campaigns across organizations.

Following completion of the study, we will work with partner organizations to make these tools available to all Canadian healthcare organizations.

Conditions

Interventions

BEHAVIORAL

Intervention Group

This group of healthcare organizations will be given the Guide, web-based tools and access to a Guide facilitator throughout the study.

BEHAVIORAL

Control Group

This group will provide their immunization rates for the base and study years and will provide information on their campaign activities. No other intervention will be provided.

Sponsors & Collaborators

  • Bruyère Health Research Institute.

    collaborator OTHER

  • Canadian Center for Vaccinology

    collaborator OTHER

  • Ottawa Hospital Research Institute

    lead OTHER

Principal Investigators

  • Larry W Chambers, PhD(Epi) · Bruyère Health Research Institute.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2012-03-31
Completion
2012-08-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01207518 on ClinicalTrials.gov